1. Home
  2. RYTM vs GLNG Comparison

RYTM vs GLNG Comparison

Compare RYTM & GLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • GLNG
  • Stock Information
  • Founded
  • RYTM 2008
  • GLNG 1946
  • Country
  • RYTM United States
  • GLNG Bermuda
  • Employees
  • RYTM N/A
  • GLNG N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • GLNG Marine Transportation
  • Sector
  • RYTM Health Care
  • GLNG Consumer Discretionary
  • Exchange
  • RYTM Nasdaq
  • GLNG Nasdaq
  • Market Cap
  • RYTM 4.3B
  • GLNG 4.4B
  • IPO Year
  • RYTM 2017
  • GLNG N/A
  • Fundamental
  • Price
  • RYTM $65.25
  • GLNG $40.25
  • Analyst Decision
  • RYTM Strong Buy
  • GLNG Strong Buy
  • Analyst Count
  • RYTM 12
  • GLNG 3
  • Target Price
  • RYTM $77.50
  • GLNG $51.83
  • AVG Volume (30 Days)
  • RYTM 560.2K
  • GLNG 1.6M
  • Earning Date
  • RYTM 08-05-2025
  • GLNG 01-01-0001
  • Dividend Yield
  • RYTM N/A
  • GLNG 2.44%
  • EPS Growth
  • RYTM N/A
  • GLNG N/A
  • EPS
  • RYTM N/A
  • GLNG 0.03
  • Revenue
  • RYTM $136,863,000.00
  • GLNG $257,915,000.00
  • Revenue This Year
  • RYTM $37.56
  • GLNG $63.76
  • Revenue Next Year
  • RYTM $74.99
  • GLNG N/A
  • P/E Ratio
  • RYTM N/A
  • GLNG $1,121.48
  • Revenue Growth
  • RYTM 48.88
  • GLNG N/A
  • 52 Week Low
  • RYTM $40.46
  • GLNG $29.29
  • 52 Week High
  • RYTM $69.89
  • GLNG $44.36
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 53.08
  • GLNG 51.29
  • Support Level
  • RYTM $60.80
  • GLNG $40.70
  • Resistance Level
  • RYTM $64.00
  • GLNG $43.33
  • Average True Range (ATR)
  • RYTM 1.96
  • GLNG 1.10
  • MACD
  • RYTM -0.13
  • GLNG -0.19
  • Stochastic Oscillator
  • RYTM 44.48
  • GLNG 27.65

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its lead asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About GLNG Golar Lng Ltd

Golar LNG Ltd is a midstream LNG company that operates in the transportation, regasification, liquefaction, and trading of LNG. The segment in which the group operates includes Shipping, FLNG (Floating Liquefaction Natural Gas vessels), and Corporate and other. It generates maximum revenue from the FLNG segment.

Share on Social Networks: